In Silico Design and Computational Assessment of Small-Molecule GLP-1R Agonist As a Possible Treatment for Obesity and Type 2 Diabetes. Tikrit J. Pharm. Sci. 2026, 20 (1), 51-66. https://doi.org/10.25130/tjphs.2026.20.1.6.51.66.